New award for hydroxychloroquine SO4 tablets with concordia pharmaceuticals, INC. Period of performance is SEP 23, 2020 to SEP 22, 2021 with four one-year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79720D0053
- Awardee
-
Concordia Pharmaceuticals Inc. UEI NNMGM5SLUJM3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Hydroxychloroquine Tablets (VA-20-00039800) 200mg Pre-Solicitation · 36E79720R0037 · Posted Apr 24, 2020
- 6505--Hydroxychloroquine SO4 Tablets (VA-20-00039800) Effective 9/23/2020 - 9/22/2021 Award Notice · Posted Aug 19, 2020
- 6505--Hydroxychloroquine Tablets (VA-20-00039800) 200mg Solicitation · Posted May 11, 2020
- Last date to order 100% complete
- IDV ceiling
- $20,293,080.60
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is a single-award indefinite delivery contract awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Concordia Pharmaceuticals Inc. for the procurement of Hydroxychloroquine SO4 200mg tablets. The contract has a total ceiling value of $20,293,080.60 and a period of performance from September 23, 2020 to September 22, 2025, with an initial one-year base period and four one-year option periods.
The contract aims to provide an uninterrupted supply of Hydroxychloroquine SO4 tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The tablets will be distributed through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. The contract was awarded on a full and open competition basis, with no set-asides used. Concordia Pharmaceuticals, as the prime contractor, must be able to meet the estimated annual requirement of 269,139 bottles of the 200mg tablets.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 25
Quick answers
Who was awarded contract 36E79720D0053?
36E79720D0053 was awarded to Concordia Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on September 23, 2020.
How much is contract 36E79720D0053 worth?
36E79720D0053's own ceiling is $20,293,081.
Who can order from contract 36E79720D0053?
36E79720D0053 is a single award indefinite delivery contract.
Was contract 36E79720D0053 competed?
The extent of competition for 36E79720D0053 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV